Prihlásiť sa Zaregistrujte sa zadarmo

Akcie v obehu spoločnosti Beam Therapeutics

Aká je hodnota metriky Akcie v obehu spoločnosti Beam Therapeutics?

Hodnota metriky Akcie v obehu spoločnosti Beam Therapeutics Inc. je 54.087M 79.38%

Aká je definícia metriky Akcie v obehu?

Akcie v obehu (Shares float) je podiel akcií spoločnosti vlastnených verejnými investormi voči zablokovaným akciám (nie sú voľne v obehu).

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Akcie v obehu spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Beam Therapeutics

Čomu sa venuje spoločnosť Beam Therapeutics?

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Firmy s metrikou akcie v obehu podobnou spoločnosti Beam Therapeutics



  • Hodnota metriky Akcie v obehu spoločnosti ASOS Plc je 53.982M 54.01%
  • Hodnota metriky Akcie v obehu spoločnosti ASOS Plc je 53.982M 54.01%
  • Hodnota metriky Akcie v obehu spoločnosti Sino Gas je 54.000M 25.00%
  • Hodnota metriky Akcie v obehu spoločnosti TAO Commodities je 54.001M 172.05%
  • Hodnota metriky Akcie v obehu spoločnosti India Steel Works je 54.008M 13.57%
  • Hodnota metriky Akcie v obehu spoločnosti Computer And Technologies je 54.062M 21.67%
  • Hodnota metriky Akcie v obehu spoločnosti Beam Therapeutics je 54.087M 79.38%
  • Hodnota metriky Akcie v obehu spoločnosti Whirlpool je 54.090M 89.05%
  • Hodnota metriky Akcie v obehu spoločnosti Whirlpool je 54.090M 84.77%
  • Hodnota metriky Akcie v obehu spoločnosti Majestic Wine Plc je 54.092M 73.66%
  • Hodnota metriky Akcie v obehu spoločnosti Cache Exploration je 54.099M 104.77%
  • Hodnota metriky Akcie v obehu spoločnosti Petrox Resources je 54.111M 98.15%
  • Hodnota metriky Akcie v obehu spoločnosti CannPal Animal Therapeutics je 54.118M 58.11%